Beam Therapeutics, Cambridge, MA, USA.
Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Nat Biotechnol. 2020 Jul;38(7):892-900. doi: 10.1038/s41587-020-0491-6. Epub 2020 Apr 13.
The foundational adenine base editors (for example, ABE7.10) enable programmable A•T to G•C point mutations but editing efficiencies can be low at challenging loci in primary human cells. Here we further evolve ABE7.10 using a library of adenosine deaminase variants to create ABE8s. At NGG protospacer adjacent motif (PAM) sites, ABE8s result in ~1.5× higher editing at protospacer positions A5-A7 and ~3.2× higher editing at positions A3-A4 and A8-A10 compared with ABE7.10. Non-NGG PAM variants have a ~4.2-fold overall higher on-target editing efficiency than ABE7.10. In human CD34 cells, ABE8 can recreate a natural allele at the promoter of the γ-globin genes HBG1 and HBG2 with up to 60% efficiency, causing persistence of fetal hemoglobin. In primary human T cells, ABE8s achieve 98-99% target modification, which is maintained when multiplexed across three loci. Delivered as messenger RNA, ABE8s induce no significant levels of single guide RNA (sgRNA)-independent off-target adenine deamination in genomic DNA and very low levels of adenine deamination in cellular mRNA.
基础腺嘌呤碱基编辑器(例如,ABE7.10)可实现可编程的 A•T 到 G•C 点突变,但在原代人细胞中的挑战性基因座上,编辑效率可能较低。在这里,我们使用腺嘌呤脱氨酶变体文库进一步进化 ABE7.10,从而创建 ABE8。在 NGG 原间隔基序(PAM)位点,与 ABE7.10 相比,ABE8 在原间隔子位置 A5-A7 处的编辑效率提高了约 1.5 倍,在位置 A3-A4 和 A8-A10 处的编辑效率提高了约 3.2 倍。非 NGG PAM 变体的靶标编辑效率总体比 ABE7.10 高约 4.2 倍。在人 CD34 细胞中,ABE8 可以以高达 60%的效率在 γ-珠蛋白基因 HBG1 和 HBG2 的启动子处重新创建天然等位基因,从而持续产生胎儿血红蛋白。在原代人 T 细胞中,ABE8 可实现 98-99%的靶标修饰,当在三个基因座上进行多重编辑时,仍能保持这一修饰水平。作为信使 RNA 递送时,ABE8 在基因组 DNA 中不会诱导显著水平的 sgRNA 非依赖性脱靶腺嘌呤脱氨,在细胞 mRNA 中也不会诱导低水平的腺嘌呤脱氨。